Contact us

Anna-Karin joined SDS Group in 2019 and is one of the co-founders of SDS MedteQ. She holds a Master of Science degree in Mechanical Engineering from the Royal Institute of Technology (KTH) in Stockholm, Sweden. With 20 years’ career experience in medical device companies, working in departments such as Development, Research, Project Management, and Operational Excellence, Anna-Karin appreciates the challenge of defining and improving organizations and their quality and compliance work. Anna-Karin is the founding CEO of SDS MedteQ, a rapidly expanding team of skilled quality, regulatory and project management consultants specialising in medical technologies.

Anna is one of the co-founders of Scandinavian Development Services (SDS) Group and holds a PhD in Biostatistics from Karolinska Institutet, Stockholm. Her varied experience comes from work within regulatory authorities, the pharmaceutical industry and academic research. Anna served as a Clinical Assessor and the Head of the Pharmacotherapeutic section at the Norwegian Medicines Agency and as a Statistician at the Swedish Institute for Infectious Disease Control. In addition, she has long-standing industry experience as a consultant within regulatory affairs and drug clinical trials at Pfizer Pharmaceuticals, Pharmacia & Upjohn and Zeneca Pharmaceuticals, to name a few.

Anna Törners main expertise lies within clinical development and design of clinical trials. She is particularly interested in merging statistical and regulatory knowledge to create studies better suited for regulatory needs.

Anna Holmberg serves as Business Director for SDS MedteQ's Lund office and leads SDS MedteQ's business development in Southern Sweden. Anna brings to SDS MedteQ more than 20 years’ experience from managing research and development projects in the life science sector and holds a PhD in Physical Chemistry from Lund University, Sweden. Prior to joining SDS, Anna has held several leadership positions. She was Associate Director, Regulatory Affairs CMC at AstraZeneca. She was also former CEO of Pharmiva AB, a Swedish medical device company focused Female healthcare technology products. In addition, she was also former CEO of Zelmic AB, a CRO focused on the development of topical and transdermal pharmaceutical formulations.

Through her unique cross-disciplinary background cutting across academia and industry, she closely understands and navigates the many business challenges of life science companies, be it, early-stage startups or multinational corporations. 

Lars is a highly experienced management and business consultant specialising within the pharmaceutical and biotechnology industry. He currently serves as the Business Director at SDS MedteQ’s Oslo office and the Chairman of the Life Science Cluster, Oslo, Norway. He also currently serves as board member of Vaccibody AS, a clinical stage company developing targeted DNA vaccines and Palion Medical AS, a medical device company developing precision medicine-based solutions for the treatment of severe headache disorders.

Lars has also served as the CEO of Bringwell AB(pub), a Nordic health and welfare company listed in Stockholm, that commercializes OTC pharmaceuticals, nutrition and food supplements. He has also been Managing Director of MSD Norway (Merck & Co Inc. subsidiary) for 10 years and has more than twenty-five years’ experience from various executive positions within marketing and sales at Merck.